Ciprofloxacin-d4
Ciprofloxacin-d4 (Bay-09867-d4) is deuterium labeled Ciprofloxacin. Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].
Product Specifications
Product Name Alternative
Bay-09867-d4
UNSPSC
12352005
Target
Antibiotic; Apoptosis; Bacterial; Isotope-Labeled Compounds; Mitochondrial Metabolism; Reactive Oxygen Species (ROS) ; Topoisomerase
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Others
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Smiles
O=C(C1=CN(C2C([2H])([2H])C2([2H])[2H])C3=CC(N4CCNCC4)=C(C=C3C1=O)F)O
Molecular Formula
C17H14D4FN3O3
Molecular Weight
335.37
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MEOX 2 (MEOX2) (NM_005924) Human Recombinant Protein
